<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/mostaccessed/journal?journal=bmcgeriatr&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Geriatrics - Most accessed articles</title>
        <link>http://www.biomedcentral.com/bmcgeriatr/</link>
        <description>The most accessed research articles published by BMC Geriatrics</description>
        <dc:date>2009-11-19T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/6/3" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/47" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/7/1" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/46" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/44" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/48" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/30" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/39" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/45" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2318/9/49" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/6/3">
        <title>Pain in elderly people with severe dementia: A systematic review of behavioural pain assessment tools</title>
        <description>Background:
Pain is a common and major problem among nursing home residents. The prevalence of pain in elderly nursing home people is 40&#8211;80%, showing that they are at great risk of experiencing pain. Since assessment of pain is an important step towards the treatment of pain, there is a need for manageable, valid and reliable tools to assess pain in elderly people with dementia.
Methods:
This systematic review identifies pain assessment scales for elderly people with severe dementia and evaluates the psychometric properties and clinical utility of these instruments. Relevant publications in English, German, French or Dutch, from 1988 to 2005, were identified by means of an extensive search strategy in Medline, Psychinfo and CINAHL, supplemented by screening citations and references. Quality judgement criteria were formulated and used to evaluate the psychometric aspects of the scales.
Results:
Twenty-nine publications reporting on behavioural pain assessment instruments were selected for this review. Twelve observational pain assessment scales (DOLOPLUS2; ECPA; ECS; Observational Pain Behavior Tool; CNPI; PACSLAC; PAINAD; PADE; RaPID; Abbey Pain Scale; NOPPAIN; Pain assessment scale for use with cognitively impaired adults) were identified. Findings indicate that most observational scales are under development and show moderate psychometric qualities.
Conclusion:
Based on the psychometric qualities and criteria regarding sensitivity and clinical utility, we conclude that PACSLAC and DOLOPLUS2 are the most appropriate scales currently available. Further research should focus on improving these scales by further testing their validity, reliability and clinical utility.</description>
        <link>http://www.biomedcentral.com/1471-2318/6/3</link>
                <dc:creator>Sandra Zwakhalen</dc:creator>
                <dc:creator>Jan Hamers</dc:creator>
                <dc:creator>Huda Huijer Abu-Saad</dc:creator>
                <dc:creator>Martijn Berger</dc:creator>
                <dc:source>BMC Geriatrics 2006, 6:3</dc:source>
        <dc:date>2006-01-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-6-3</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2006-01-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/47">
        <title>A frailty index to predict the mortality risk in a population of senior mexican adults </title>
        <description>Background:
Frailty in the elderly can be regarded as nonspecific vulnerability to adverse health outcomes, caused by multiple factors. The aim was to analyze the relationships between the frailty index, age and mortality in a two year follow up study of Mexican elderly.
Methods:
A frailty index was developed using 34 variables. To obtain the index, the mean of the total score for each individual was obtained. Survival analyses techniques were used to examine the risk ratios for the different levels of the frailty index. Kaplan-Meier estimates were obtained, adjusted for age and gender. Cox proportional hazards models were also built to obtain hazard ratio estimates.
Results:
A total of 4082 participants was analyzed. Participants had an average age of 73 years and 52.5% were women. On average, participants were followed-up for 710 days (standard deviation = 111 days) and 279 of them died. Mortality increased with the frailty index level, especially in those with levels between .21 to .65, reaching approximately 17% and 21%, respectively. Cox proportional hazards models showed that participants with frailty index levels associated to increased mortality (.21 and higher) represent 24.0% of those aged 65-69 years and 47.6% of those 85 and older.
Conclusion:
The frailty index shows the properties found in the other studies, it allows stratifying older Mexican into several groups different by the degree of the risk of mortality, and therefore the frailty index can be used in assessing health of elderly.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/47</link>
                <dc:creator>Jose Garcia-Gonzalez</dc:creator>
                <dc:creator>Carmen Garcia-Pena</dc:creator>
                <dc:creator>Francisco Franco-Marina</dc:creator>
                <dc:creator>Luis Gutierrez-Robledo</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:47</dc:source>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-47</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>47</prism:startingPage>
        <prism:publicationDate>2009-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/7/1">
        <title>The association between timed up and go test and history of falls: The Tromso study</title>
        <description>Background:
Fall-related injuries in older adults are a major health problem. Although the aetiology of falls is multifactorial, physical factors are assumed to contribute significantly. The &quot;Timed up and go test&quot; (TUG) is designed to measure basic mobility function. This report evaluates the association between TUG times and history of falls.
Methods:
A retrospective, observational, population-based study was conducted on 414 men and 560 women with mean age 77.5 (SD 2.3). TUG time and falls during the previous 12 months were recorded. Covariates were age, sex, medical history and health-related mobility problems. Means, confidence intervals and test characteristics for TUG were calculated. Odds ratios and influence of covariates were examined by logistic regression.
Results:
The mean TUG time was 11.1s (SD 2.5) among male non-fallers and 13.0s (SD 7.8) among fallers. The difference was 1.9s (95%CI 0.9&#8211;3.0). The odds ratio for fallers being in the upper quartile was 2.1 (95%CI 1.4&#8211;3.3). Adjusted for covariates, the odds ratio was (OR = 1.8, 95%CI 1.1&#8211;2.9). The corresponding mean was 13.0s (SD 5.74) among female non-fallers and 13.9s (SD 8.5) among fallers. The difference was 0.9 (95%CI -0.3&#8211;2.1). The odds ratio for fallers being in upper quartile was 1.0 (95%CI 0.7&#8211;1.4). The area under the ROC curve was 0.50 (95%CI 0.45&#8211;0.55) in women and 0.56 (95%CI 0.50&#8211;0.62) in men.
Conclusion:
TUG is statistically associated with a history of falls in men but not in women. The ability to classify fallers is poor, and the clinical value of the association is therefore limited.</description>
        <link>http://www.biomedcentral.com/1471-2318/7/1</link>
                <dc:creator>Gyrd Thrane</dc:creator>
                <dc:creator>Ragnar Joakimsen</dc:creator>
                <dc:creator>Eline Thornquist</dc:creator>
                <dc:source>BMC Geriatrics 2007, 7:1</dc:source>
        <dc:date>2007-01-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-7-1</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2007-01-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/46">
        <title>Falls among community-residing stroke survivors following inpatient
rehabilitation: a descriptive analysis of longitudinal data</title>
        <description>Background:
Stroke victims are at relatively high risk for injurious falls. The purpose of this study was to document longitudinal fall patterns following inpatient rehabilitation for first-time stroke survivors.
Methods:
Participants (n = 231) were recruited at the end of their rehab stay and interviewed monthly via telephone for 1 to 32 months regarding fall incidents. Analyses were conducted on: total reports of falls by month over time for first-time and repeat fallers, the incidence of falling in any given month; and factors differing between fallers and non fallers.
Results:
The largest percentage of participants (14%) reported falling in the first month post-discharge. After month five, less than 10% of the sample reported falling, bar months 15 (10.4%) and 23 (13.2%). From months one to nine, the percentage of those reporting one fall with and without a prior fall were similar. After month nine, the number of individuals who reported a single fall with a fall history was twice as high compared to those without a prior fall who reported falling. In both cases the percentages were small. A very small subset of the population emerged who fell multiple times each month, most of whom had a prior fall history. At least a third of the sample reported a loss of balance each month. Few factors differed significantly between fallers and non-fallers in months one to six.
Conclusion:
Longitudinal data suggest that falls most likely linked to first time strokes occur in the first six months post discharge, particularly month one. Data routinely available at discharge does not distinguish fallers from non-fallers. Once a fall incident has occurred however, preventive intervention is warranted.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/46</link>
                <dc:creator>Laura Wagner</dc:creator>
                <dc:creator>Victoria Phillips</dc:creator>
                <dc:creator>Amanda Hunsaker</dc:creator>
                <dc:creator>Pamela Forducey</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:46</dc:source>
        <dc:date>2009-10-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-46</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>46</prism:startingPage>
        <prism:publicationDate>2009-10-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/44">
        <title>WHEDA study: Effectiveness of occupational therapy at home for older people with dementia and their caregivers - the design of a pragmatic randomised controlled trial evaluating a Dutch programme in seven German centres</title>
        <description>Background:
A recent Dutch mono-centre randomised controlled trial has shown that occupational therapy improves daily functioning in dementia. The aim of this present study is to compare the effects of the Dutch community occupational therapy programme with a community occupational therapy consultation on daily functioning in older people with mild or moderate dementia and their primary caregivers in a German multi-centre context.Methods/DesignA multi-centre single blind randomised controlled trial design is being used in seven health care centres (neurological, psychiatric and for older people) in urban regions. Patients are 1:1 randomised to treatment or control group. Assessors are blind to group assignment and perform measurements on both groups at baseline, directly after intervention at 6 weeks and at 16, 26 and 52 weeks follow-up. A sample of 140 community dwelling older people (aged &gt;65 years) with mild or moderate dementia and their primary caregivers is planned. The experimental intervention consists of an evidence-based community occupational therapy programme including 10 sessions occupational therapy at home. The control intervention consists of one community occupational therapy consultation based on information material of the Alzheimer Society. Providers of both interventions are occupational therapists experienced in treatment of cognitively impaired older people and trained in both programmes. &apos;Community&apos; indicates that occupational therapy intervention occurs in the person&apos;s own home. The primary outcome is patients&apos; daily functioning assessed with the performance scale of the Interview for Deterioration in Daily Living Activities in Dementia and video tapes of daily activities rated by external raters blind to group assignment using the Perceive, Recall, Plan and Perform System of Task Analysis. Secondary outcomes are patients&apos; and caregivers&apos; quality of life, mood and satisfaction with treatment; the caregiver&apos;s sense of competence, caregiver&apos;s diary (medication, resource utilisation, time of informal care); and the incidence of long-term institutionalisation. Process evaluation is performed by questionnaires and focus group discussion.DiscussionThe transfer from the Dutch mono-centre design to the pragmatic multi-site trial in a German context implicates several changes in design issues including differences in recruitment time, training of interventionists and active control group treatment.The study is registered under DRKS00000053 at the German register of clinical trials, which is connected to the International Clinical Trials Registry Platform.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/44</link>
                <dc:creator>Sebastian Voigt-Radloff</dc:creator>
                <dc:creator>Maud Graff</dc:creator>
                <dc:creator>Rainer Leonhart</dc:creator>
                <dc:creator>Katrin Schornstein</dc:creator>
                <dc:creator>Myrra Vernooij-Dassen</dc:creator>
                <dc:creator>Marcel Olde-Rikkert</dc:creator>
                <dc:creator>Michael Huell</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:44</dc:source>
        <dc:date>2009-10-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-44</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>44</prism:startingPage>
        <prism:publicationDate>2009-10-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/48">
        <title>The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition.</title>
        <description>Background:
Prior evidence suggests that the renin angiotensin system and antihypertensives that inhibit this system play a role in cognitive, central vascular, and endothelial function. Our objective is to conduct a double-blind randomized controlled clinical trial, the antihypertensives and vascular, endothelial, and cognitive function (AVEC), to compare 1 year treatment of 3 antihypertensives (lisinopril, candesartan, or hydrochlorothiazide) in their effect on memory and executive function, cerebral blood flow, and central endothelial function of seniors with hypertension and early objective evidence of executive or memory impairments.Methods/DesignThe overall experimental design of the AVEC trial is a 3-arm double blind randomized controlled clinical trial. A total of 100 community eligible individuals (60 years or older) with hypertension and early cognitive impairment are being recruited from the greater Boston area and randomized to lisinopril, candesartan, or hydrochlorothiazide (&quot;active control&quot;) for 12 months. The goal of the intervention is to achieve blood pressure control defined as SBP &lt; 140 mm Hg and DBP &lt; 90 mm Hg. Additional antihypertensives are added to achieve this goal if needed. Eligible participants are those with hypertension, defined as a blood pressure 140/90 mm Hg or greater, early cognitive impairment without dementia defined (10 or less out of 15 on the executive clock draw test or 1 standard deviation below the mean on the immediate memory subtest of the repeatable battery for the assessment of neuropsychological status and Mini-Mental-Status-exam &gt;20 and without clinical diagnosis of dementia or Alzheimer&apos;s disease). Individuals who are currently receiving antihypertensives are eligible to participate if the participants and the primary care providers are willing to taper their antihypertensives. Participants undergo cognitive assessment, measurements of cerebral blood flow using Transcranial Doppler, and central endothelial function by measuring changes in cerebral blood flow in response to changes in end tidal carbon dioxide at baseline (off antihypertensives), 6, and 12 months. Our outcomes are change in cognitive function score (executive and memory), cerebral blood flow, and carbon dioxide cerebral vasoreactivity.DiscussionThe AVEC trial is the first study to explore impact of antihypertensives in those who are showing early evidence of cognitive difficulties that did not reach the threshold of dementia. Success of this trial will offer new therapeutic application of antihypertensives that inhibit the renin angiotensin system and new insights in the role of this system in aging.Trial RegistrationClinicaltrials.gov NCT00605072</description>
        <link>http://www.biomedcentral.com/1471-2318/9/48</link>
                <dc:creator>Ihab Hajjar</dc:creator>
                <dc:creator>Meaghan Hart</dc:creator>
                <dc:creator>William Milberg</dc:creator>
                <dc:creator>Vera Novak</dc:creator>
                <dc:creator>Lewis Lipsitz</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:48</dc:source>
        <dc:date>2009-11-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-48</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>48</prism:startingPage>
        <prism:publicationDate>2009-11-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/30">
        <title>Inappropriate medication use and risk of falls - A prospective study in a large community-dwelling elderly cohort
</title>
        <description>Background:
Explicit criteria for determining potentially inappropriate medication consumption in elderly were elaborated by Beers et al. These lists have been used worldwide to evaluate medical prescriptions but there is little epidemiologic evidence demonstrating negative consequences of inappropriate medication use. It has been reported that some drugs could increase the risk of falls, which are a frequent and serious problem in elderly population. We aimed to evaluate the association between the use of potentially inappropriate medications and the risk of falls.
Methods:
The 3C Study is a multicentre prospective cohort study conducted in France with 4 years of follow-up. Non-institutionalized men and women aged 65 years or over (N = 6343) were randomly selected from electoral rolls. Data on socio-demographic, medical characteristics and medication use (based on self-reports and data from the national healthcare insurance) were collected. Use of inappropriate medication for elderly was defined from established criteria. Data about falls were collected at the two follow-up examinations (2 years and 4 years after baseline). The association between the exposure to inappropriate medications and the risk of falls was evaluated using multivariate models (Cox model and logistic regression).
Results:
32% of subjects reported inappropriate medication use at baseline and 29% at least two of the three examinations; 22% had fallen 2 times or more during follow-up. Overall, inappropriate medication users had an increased risk of falling. This increase was mainly due to the use of long-acting benzodiazepines (adjusted odds ratio (OR) = 1.4, 95% confidence interval: [1.1&#8211;1.8], in both occasional and regular users), other inappropriate psychotropics (adjusted OR = 1.7 [1.7&#8211;2.7] in regular users), or medication with anticholinergic properties (adjusted OR = 1.6 [1.2&#8211;2.1] in regular users). Neither occasional, nor regular use of short- or intermediate-acting benzodiazepines was associated with an increased risk of falling. Further analysis in long-acting benzodiazepines users did not show any dose-effect relation between the number of prescriptions filled over a 3-year period and the risk of falling.
Conclusion:
Our study showed that use of inappropriate medications was associated with an increased risk of falling in elderly persons. This increase was mainly due to long-acting benzodiazepines and other inappropriate psychotropics, and to medications with anticholinergic properties.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/30</link>
                <dc:creator>Sarah Berdot</dc:creator>
                <dc:creator>Marion Bertrand</dc:creator>
                <dc:creator>Jean-Francois Dartigues</dc:creator>
                <dc:creator>Annie Fourrier</dc:creator>
                <dc:creator>Beatrice Tavernier</dc:creator>
                <dc:creator>Karen Ritchie</dc:creator>
                <dc:creator>Annick Alperovitch</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:30</dc:source>
        <dc:date>2009-07-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-30</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>30</prism:startingPage>
        <prism:publicationDate>2009-07-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/39">
        <title>Are non-slip socks really &apos;non-slip&apos;? An Analysis of slip resistance.</title>
        <description>Background:
Non-slip socks have been suggested as a means of preventing accidental falls due to slips. This study compared the relative slip resistance of commercially available non-slip socks with other foot conditions, namely bare feet, compression stockings and conventional socks, in order to determine any traction benefit.
Methods:
Phase one involved slip resistance testing of two commercially available non-slip socks and one compression-stocking sample through an independent blinded materials testing laboratory using a Wet Pendulum Test.Phase two of the study involved in-situ testing among healthy adult subjects (n = 3). Subjects stood unsupported on a variable angle, inclined platform topped with hospital grade vinyl, in a range of foot conditions (bare feet, non-slip socks, conventional socks and compression stockings). Inclination was increased incrementally for each condition until slippage of any magnitude was detected. The platform angle was monitored using a spatial orientation tracking sensor and slippage point was recorded on video.
Results:
Phase one results generated through Wet Pendulum Test suggested that non-slip socks did not offer better traction than compression stockings. However, in phase two, slippage in compression stockings was detected at the lowest angles across all participants. Amongst the foot conditions tested, barefoot conditions produced the highest slip angles for all participants indicating that this foot condition provided the highest slip resistance.
Conclusion:
It is evident that bare feet provide better slip resistance than non-slip socks and therefore might represent a safer foot condition. This study did not explore whether traction provided by bare feet was comparable to &apos;optimal&apos; footwear such as shoes. However, previous studies have associated barefoot mobilisation with increased falls. Therefore, it is suggested that all patients continue to be encouraged to mobilise in appropriate, well-fitting shoes whilst in hospital. Limitations of this study in relation to the testing method, participant group and sample size are discussed.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/39</link>
                <dc:creator>Satyan Chari</dc:creator>
                <dc:creator>Terrence Haines</dc:creator>
                <dc:creator>Paul Varghese</dc:creator>
                <dc:creator>Alyssia Economidis</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:39</dc:source>
        <dc:date>2009-08-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-39</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>39</prism:startingPage>
        <prism:publicationDate>2009-08-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/45">
        <title>Self reported health status, and health service contact, of illicit drug users aged 50 and over: a qualitative interview study in Merseyside, United Kingdom</title>
        <description>Background:
The populations of industrialised countries are ageing; as this occurs, those who continue to use alcohol and illicit drugs age also. While alcohol use among older people is well documented, use of illicit drugs continues to be perceived as behaviour of young people and is a neglected area of research. This is the first published qualitative research on the experiences of older drug users in the United Kingdom.
Methods:
Semi-structured interviews were conducted in Merseyside, in 2008, with drug users aged 50 and over recruited through drug treatment services. Interviews were recorded and transcribed and analysed thematically. Only health status and health service contact are reported here.
Results:
Nine men and one woman were interviewed (age range: 54 to 61 years); all but one had been using drugs continuously or intermittently for at least 30 years. Interviewees exhibited high levels of physical and mental morbidity; hepatitis C was particularly prevalent. Injecting-related damage to arm veins resulted in interviewees switching to riskier injecting practices. Poor mental health was evident and interviewees described their lives as depressing. The death of drug-using friends was a common theme and social isolation was apparent. Interviewees also described a deterioration of memory. Generic healthcare was not always perceived as optimal, while issues relating to drug specific services were similar to those arising among younger cohorts of drug users, for example, complaints about inadequate doses of prescribed medication.
Conclusion:
The concurrent effects of drug use and ageing are not well understood but are thought to exacerbate, or accelerate the onset of, medical conditions which are more prevalent in older age. Here, interviewees had poor physical and mental health but low expectations of health services. Older drug users who are not in contact with services are likely to have greater unmet needs. The number of drug users aged 50 and over is increasing in Europe and America; this group represent a vulnerable, and in Europe, a largely hidden population. Further work to evaluate the impact of this change in demography is urgently needed.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/45</link>
                <dc:creator>Caryl Beynon</dc:creator>
                <dc:creator>Brenda Roe</dc:creator>
                <dc:creator>Paul Duffy</dc:creator>
                <dc:creator>Lucy Pickering</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:45</dc:source>
        <dc:date>2009-10-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-45</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>45</prism:startingPage>
        <prism:publicationDate>2009-10-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2318/9/49">
        <title>Inverse association between insulin resistance and gait speed in nondiabetic older men: Results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999-2002</title>
        <description>Background:
Recent studies have revealed the associations between insulin resistance (IR) and geriatric conditions such as frailty and cognitive impairment. However, little is known about the relation of IR to physical impairment and limitation in the aging process, eg. slow gait speed and poor muscle strength. The aim of this study is to determine the effect of IR in performance-based physical function, specifically gait speed and leg strength, among nondiabetic older adults.
Methods:
Cross-sectional data were from the population-based National Health and Nutrition Examination Survey (1999-2002). A total of 1168 nondiabetic adults (&#8805; 50 years) with nonmissing values in fasting measures of insulin and glucose, habitual gait speed (HGS), and leg strength were analyzed. IR was assessed by homeostasis model assessment (HOMA-IR), whereas HGS and peak leg strength by the 20-foot timed walk test and an isokinetic dynamometer, respectively. We used multiple linear regression to examine the association between IR and performance-based physical function.
Results:
IR was inversely associated with gait speed among the men. After adjusting demographics, body mass index, alcohol consumption, smoking status, chronic co-morbidities, and markers of nutrition and cardiovascular risk, each increment of 1 standard deviation in the HOMA-IR level was associated with a 0.04 m/sec decrease (p = 0.003) in the HGS in men. We did not find such association among the women. The IR-HGS association was not changed after further adjustment of leg strength. Last, HOMA-IR was not demonstrated in association with peak leg strength.
Conclusion:
IR is inversely associated with HGS among older men without diabetes. The results suggest that IR, an important indicator of gait function among men, could be further investigated as an intervenable target to prevent walking limitation.</description>
        <link>http://www.biomedcentral.com/1471-2318/9/49</link>
                <dc:creator>Chen-Ko Kuo</dc:creator>
                <dc:creator>Lian-Yu Lin</dc:creator>
                <dc:creator>Yau-Hua Yu</dc:creator>
                <dc:creator>Kuan-Han Wu</dc:creator>
                <dc:creator>Hsu-Ko Kuo</dc:creator>
                <dc:source>BMC Geriatrics 2009, 9:49</dc:source>
        <dc:date>2009-11-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2318-9-49</dc:identifier>
        <prism:publicationName>BMC Geriatrics</prism:publicationName>
        <prism:issn>1471-2318</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>49</prism:startingPage>
        <prism:publicationDate>2009-11-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
